Cycle Ventures News Today

In just three years, Farmington-based medical device company CytoVeris has gone from a small startup with the goal of helping surgeons better detect cancer, to a company that’s raised $8 million and hired 19 employees, with plans to add six more in the year ahead. More importantly, its cancer detection device has made strides; a feasibility study is scheduled to take place in the spring, while clinical trials could start in early 2023, company officials said.

Lumeda Announces Closing of $4.3M Series A Financing with Clinical Studies Due to Commence in 2021 Share Article Funding to advance product design and clinical testing as company strives to improve outcomes for lung cancer patients ROCKY HILL, Conn. (PRWEB) April 08, 2021 Lumeda Inc., a medical technology company advancing Photodynamic Therapy (PDT) as an intraoperative adjuvant treatment for patients during lung cancer surgery, to...